MedTrace Logo

Erector Spinae Plane Block With Ropivacaine for Major Upper Abdominal Surgery

NCT04702685 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-01-11

No results posted yet for this study

Summary

Prospective, single-centre, randomized, controlled, open-label, evaluator-blinded, superiority trial.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Ropivacaine

Local anesthetic for injection

OTHER

Placebo

Bandage will be placed in the presumed injection site while patients in under general anesthesia

Sponsors & Collaborators

  • National Research Oncology and Transplantology Center, Kazakhstan

    collaborator OTHER

  • Nazarbayev University Medical Center

    lead OTHER

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-31
Primary Completion
2021-05-31
Completion
2021-08-31

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04702685 on ClinicalTrials.gov